9.48
price up icon4.52%   0.41
pre-market  Vorhandelsmarkt:  9.84   0.36   +3.80%
loading

Leonabio Inc Aktie (LONA) Neueste Nachrichten

pulisher
Apr 13, 2026

28,000-share stock option grant to LeonaBio (LONA) director - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

LeonaBio (LONA) awards 300,000 stock options to chief scientific officer - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

28,000 stock options granted to LeonaBio (LONA) director Kosacz - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

LeonaBio (LONA) director Grant Pickering receives 28,000 stock options - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

Director Romano Kelly receives 28,000 LeonaBio (LONA) stock options at $9.54 - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

LeonaBio (LONA) director receives options to buy 28,000 shares at $9.54 - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

LeonaBio (LONA) director awarded options on 28,000 shares at $9.54 - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

LeonaBio (LONA) grants CMO 350,000 options at $9.54 - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

Director John M. Fluke Jr. receives 28,000-share option grant at LeonaBio (LONA) - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

LeonaBio (LONA) awards 300,000 stock options to general counsel - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

LeonaBio (LONA) CFO awarded 300,000 stock options at $9.54 - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

LeonaBio (LONA) CEO awarded 750,000 stock options at $9.54 strike - Stock Titan

Apr 13, 2026
pulisher
Apr 12, 2026

LONA: LeonaBio, Inc.Comparison to Industry - Zacks Investment Research

Apr 12, 2026
pulisher
Apr 09, 2026

Leonabio discovers new pannexin-1 inhibitors - BioWorld News

Apr 09, 2026
pulisher
Apr 08, 2026

LONA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 08, 2026
pulisher
Apr 07, 2026

Cantor Fitzgerald reiterates Overweight on LeonaBio stock By Investing.com - Investing.com Canada

Apr 07, 2026
pulisher
Apr 07, 2026

Cantor Fitzgerald reiterates Overweight on LeonaBio stock - Investing.com

Apr 07, 2026
pulisher
Apr 06, 2026

Mizuho raises LeonaBio stock price target to $16 on breast cancer drug outlook By Investing.com - Investing.com South Africa

Apr 06, 2026
pulisher
Apr 06, 2026

Mizuho raises LeonaBio stock price target to $16 on breast cancer drug outlook - Investing.com India

Apr 06, 2026
pulisher
Apr 06, 2026

Mizuho Raises Price Target on LeonaBio to $16 From $10, Keeps Outperform Rating - marketscreener.com

Apr 06, 2026
pulisher
Apr 02, 2026

[EFFECT] LeonaBio, Inc. SEC Filing - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Leonabio Warns of Major Financial and Operational Risks in Lasofoxifene Program Integration - TipRanks

Apr 02, 2026
pulisher
Mar 31, 2026

LeonaBio (ATHA) clears resale of 5.5M warrant shares for Sermonix - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

LeonaBio (NASDAQ: LONA) files resale registration for PIPE warrant holders - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

LeonaBio (NASDAQ: ATHA) leans on breast cancer and ALS drugs - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

LeonaBio (NASDAQ: ATHA) expands Sermonix deal disclosure and ELAINE-3 trial spend - Stock Titan

Mar 31, 2026
pulisher
Mar 27, 2026

LeonaBio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

LeonaBio Reports 2025 Financial Results, Acquires Lasofoxifene License, and Advances Clinical Pipeline for Metastatic Breast Cancer and ALS 123 - Minichart

Mar 27, 2026
pulisher
Mar 26, 2026

LeonaBio Updates Investors on 2025 Results and Strategy - TipRanks

Mar 26, 2026
pulisher
Mar 26, 2026

LeonaBio (NASDAQ: LONA) boosts cash to fund Phase 3 breast cancer drug - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

LeonaBio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 26, 2026
pulisher
Mar 25, 2026

LeonaBio, Inc. announced that it has received $89.724073 million in funding - MarketScreener

Mar 25, 2026
pulisher
Mar 25, 2026

LeonaBio (LONA) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 25, 2026
pulisher
Mar 20, 2026

LeonaBio, Inc. Adopts 2026 Equity Incentive Plan and Amends Certificate of Incorporation – SEC 8-K Filing March 2026 - Minichart

Mar 20, 2026
pulisher
Mar 19, 2026

LeonaBio shareholders approve equity plan and increase in authorized shares - Investing.com India

Mar 19, 2026
pulisher
Mar 19, 2026

Form 8K LeonaBio Inc For: 19 March - Investing.com

Mar 19, 2026
pulisher
Mar 19, 2026

LeonaBio Expands Share Authorization to Support Future Financing - TipRanks

Mar 19, 2026
pulisher
Mar 19, 2026

LeonaBio (ATHA) wins approval for 2026 equity plan and major share increase - Stock Titan

Mar 19, 2026
pulisher
Mar 13, 2026

LeonaBio, Inc. (prev. ATHA) (LONA) Stock Price Prediction for 2026, 2030-2040 - Traders Union

Mar 13, 2026
pulisher
Mar 11, 2026

[DEFR14A] LeonaBio, Inc. Revised Proxy Statement - Stock Titan

Mar 11, 2026
pulisher
Mar 10, 2026

Renninger, LeonaBio CFO, sells $4.9k in LONA stock - Investing.com Nigeria

Mar 10, 2026
pulisher
Mar 06, 2026

LeonaBio CEO Litton sells $27,687 in shares By Investing.com - Investing.com India

Mar 06, 2026
pulisher
Mar 05, 2026

LeonaBio CEO Litton sells $27,687 in shares - Investing.com South Africa

Mar 05, 2026
pulisher
Mar 05, 2026

Renninger, LeonaBio CFO, sells $4.9k in LONA stock By Investing.com - Investing.com Canada

Mar 05, 2026
pulisher
Mar 05, 2026

LeonaBio (ATHA) counsel sells 1,328 shares to cover RSU tax bill - Stock Titan

Mar 05, 2026
pulisher
Mar 05, 2026

LeonaBio (LONA) CMO covers RSU tax bill with share sale - Stock Titan

Mar 05, 2026
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Kapitalisierung:     |  Volumen (24h):